Spelling suggestions: "subject:"mycobacterium tuberculosis,"" "subject:"nycobacterium tuberculosis,""
211 |
The roles of mycobacterial proteasome : and host intracellular pattern recognition receptor NOD2 during tuberculosis in mice /Gandotra, Sheetal. January 2008 (has links)
Thesis (Ph. D.)--Cornell University, May, 2008. / Vita. Includes bibliographical references (leaves 205-233).
|
212 |
TLR₂-dependent modulation of antigen presenting cell functions by mycobacterial lipoproteinsPecora, Nicole Danielle. January 2008 (has links)
Thesis (Ph. D.)--Case Western Reserve University, 2008. / [School of Medicine] Department of Pathology. Includes bibliographical references.
|
213 |
Stress survival in Mycobacterium tuberculosis and Mycobacterium bovis and the role of hup in Mycobacterium smegmatisWhiteford, Danelle, January 2008 (has links) (PDF)
Thesis (Ph. D.)--Washington State University, December 2008. / Title from PDF title page (viewed on July 6, 2009). "School of Molecular Biosciences." Includes bibliographical references.
|
214 |
Mycobacterium tuberculosis and the macrophage : host defenses and bacterial resistance /Vandal, Omar Haider. January 2008 (has links)
Thesis (Ph. D.)--Cornell University, January, 2008. / Vita. Includes bibliographical references (leaves 108-131).
|
215 |
The investigation of peripheral blood cellular immune responses during infection with Mycobacterium tuberculosis /Veenstra, Hannelore F. U. January 2007 (has links)
Dissertation (PhD)--University of Stellenbosch, 2007. / Bibliography. Also available via the Internet.
|
216 |
Fractionation and comparison of the lipids of human strains of Mycobacterium Tuberculosis by means of their infrared spectraKubica, George P. January 1955 (has links)
Thesis (Ph. D.)--University of Wisconsin, 1955. / Typescript. eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references (leaves [72]-79).
|
217 |
Crystal structure of dihydropteroate synthase from Mycobacterium tuberculosis /Baca, Arthur Martin. January 2000 (has links)
Thesis (Ph. D.)--University of Washington, 2000. / Vita. Includes bibliographical references (leaves 153-173).
|
218 |
Étude de co-facteurs pouvant moduler la réplication du virus de l'immunodéficience humaine de type 1 (VIH-1) et analyse de protéines de signalisation /Bernier, Richard. January 1998 (has links)
Thèse (Ph. D.) -- Université Laval, 1998. / Bibliogr.: f. 80-101. Publié aussi en version électronique.
|
219 |
The immunopathogenesis and treatment of tuberculous pericardial effusions in a population with a high prevalence of infection with the human immunodeficiency virus /Reuter, Helmuth. January 2005 (has links)
Dissertation (PhD)--University of Stellenbosch, 2005. / Bibliography. Also available via the Internet.
|
220 |
Construção de um painel com isolados clínicos de Mycobacterium tuberculosis com genes de resistência a quimioterápicos, para o estudo de novas drogas anti-TB /Miyata, Marcelo. January 2010 (has links)
Resumo: De acordo com a Organização Mundial de Saúde em 2009, 9,27 milhões de novos casos de tuberculose ocorreram em 2007. Destes novos casos, 4,9% eram multidroga resistentes. Muitas pesquisas são realizadas na procura de novas drogas com atividade contra o bacilo da tuberculose, havendo então a necessidade de se entender os mecanismos de ação destes novos compostos. Este projeto objetivou propiciar ferramentas para compreender um pouco mais sobre os mecanismos de ação de novas drogas. Isolados clínicos de M. tuberculosis foram caracterizados quanto ao seu perfil de susceptibilidade aos fármacos do esquema terapêutico e foram determinadas as mutações responsáveis por estas resistências. Com os isolados caracterizados, foi construído um painel de M. tuberculosis. Pelo REMA, os isolados foram analisados quanto ao seu perfil de susceptibilidade aos fármacos (INH, RMP, STR e ETB) e avaliados quanto à presença de mutações nos genes de resistência (inhA, katG, ahpC, rpoβ, rpsL, rrs e embB) empregando a PCR-SSCP. Pelo REMA foram avaliados 80 isolados clínicos, sendo observada a resistência a INH em 74,7%, a RMP em 51,2%, a STR em 53,7% e ao ETB em 58,7%. Nos isolados resistentes, a porcentagem de mutações encontradas nos genes foi de 20,6% para inhA, 50% para katG, 6,3% para ahpC, 60% para rpoβ, 20% para rpsL e 0% para rrs e embB. Um painel com 12 isolados foi testado frente a três novos compostos, dois derivados de INH (Cu-INH1 e Cu-INH2) e um de RMP (Cu-RMP). Verificou-se que os isolados resistentes a INH foram também resistentes a Cu-INH1 e Cu-INH2. A mesma situação foi verificada em relação à RMP, com o composto Cu-RMP. Provavelmente, estes novos compostos têm os mesmos mecanismos de ação da INH e da RMP, que são os fármacos que lhes deram origem / Abstract: According to World Health Organization in 2009, 9.27 million new TB cases occurred in 2007. Among these new cases, 4.9% were multidrug resistant. Many surveys are conducted in the search for new drugs with activity against the tuberculosis bacillus, therefore there is a need to understand the action mechanism of these new compounds. This project aimed to provide tools to understand about the action mechanisms of new drugs. M. tuberculosis clinical isolates were analyzed for their susceptibility profile to drugs, mutations responsible for resistance and a panel of these characterized isolates. The isolates were analyzed for susceptibility profile to drugs (INH, RIF, STR and ETB) and evaluated for presence of mutations in the resistance genes (inhA, katG, ahpC, rpoβ, rpsL, rrs and embB) applying the PCR-SSCP. REMA evaluated 85 clinical isolates and the resistance was observed in 74.7% to INH, 51.5% to RIF, 53.7% to STR and 58.7% to ETB. In the resistant isolates, percentage of mutations found in the genes was 20.6% for inhA, 50% for katG, 6.3% for ahpC, 60% for rpoβ, 20% for rpsL and 0% for rrs and embB. A panel of 12 isolates was tested against three new compounds, two INH-derivatives (Cu-INH1 and Cu-INH2) and one RMP-derivative (Cu-RMP). The isolates resistant to INH were also resistant to Cu-INH1 and Cu-INH2 compounds. The same situation was verified in relation to the RMP with the Cu-RMP compound, indicating that probably these three new compounds have the same action mechanism of INH and RMP drugs / Orientador: Clarice Queico Fujimura Leite / Coorientador: Cleslei Fernando Zanelli / Banca: Elsa Mases Mamizuka / Banca: Daisy Nakamura Sato / Banca: Eliana Aparecida Varanda / Banca: Mario Hiroyuki Hirata / Doutor
|
Page generated in 0.057 seconds